Allergy· 2017Q1· Review
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
- 780citations
- Q1SCImago
- 2017year
Short summary
New EAACI guidelines recommend allergen immunotherapy (AIT) for allergic rhinoconjunctivitis (AR) due to its disease-modifying potential, offering a treatment that targets underlying pathophysiology beyond symptom management.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Immunology and Allergy
Immunology and AllergyMedicine